z-logo
open-access-imgOpen Access
The 5'-untranslated region of the mouse mammary tumor virus mRNA exhibits cap-independent translation initiation
Author(s) -
Maricarmen Vallejos,
Pablo Ramdohr,
Fernando Valiente-Echeverría,
Karla Tapia,
Felipe Rodriguez-Tirado,
Fernando Lowy,
J. Pablo HuidobroToro,
John A. Dangerfield,
Marcelo López-Lastra
Publication year - 2009
Publication title -
nucleic acids research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 9.008
H-Index - 537
eISSN - 1362-4954
pISSN - 0305-1048
DOI - 10.1093/nar/gkp890
Subject(s) - biology , internal ribosome entry site , luciferase , microbiology and biotechnology , untranslated region , polyadenylation , five prime untranslated region , messenger rna , three prime untranslated region , cistron , translation (biology) , transfection , virology , gene , rna , genetics
In this study, we demonstrate the identification of an internal ribosome entry site (IRES) within the 5'-untranslated region (5'-UTR) of the mouse mammary tumor virus (MMTV). The 5'-UTR of the full-length mRNA derived from the infectious, complete MMTV genome was cloned into a dual luciferase reporter construct containing an upstream Renilla luciferase gene (RLuc) and a downstream firefly luciferase gene (FLuc). In rabbit reticulocyte lysate, the MMTV 5'-UTR was capable of driving translation of the second cistron. In vitro translational activity from the MMTV 5'-UTR was resistant to the addition of m(7)GpppG cap-analog and cleavage of eIF4G by foot-and-mouth disease virus (FMDV) L-protease. IRES activity was also demonstrated in the Xenopus laevis oocyte by micro-injection of capped and polyadenylated bicistronic RNAs harboring the MMTV-5'-UTR. Finally, transfection assays showed that the MMTV-IRES exhibits cell type-dependent translational activity, suggesting a requirement for as yet unidentified cellular factors for its optimal function.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here